RxDoctor Payments Data

Grant Ingalls

Physician Assistant · Indiana, PANPI 1487271045

Payments from drug & device makers

$7,060in general payments, 2019–2025

Across 312 payments — averaging $22.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • AbbVie$1K
  • Amgen$809
  • UCB, Inc.$718
  • Pfizer$544
  • AstraZeneca$295
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$6,88898%
  • Education$1722%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,060 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
KrystexxaPegloticase14$743,700
Humira(Cf) PenAdalimumab75$527,283
OctagamImmun Globg(Igg)/Malt/Iga Ov5011$309,246
Enbrel SureclickEtanercept28$222,119
Orencia ClickjectAbatacept38$216,161
RemicadeInfliximab41$210,182
OrenciaAbatacept/Maltose36$161,017
BenlystaBelimumab29$134,255
RinvoqUpadacitinib13$96,392
Humira PenAdalimumab14$92,871
EnbrelEtanercept12$88,336
ProliaDenosumab16$26,479
ActemraTocilizumab11$25,454
Hydroxychloroquine Sulfate268$13,695
MethotrexateMethotrexate Sodium321$10,000

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenKrystexxa, Enbrel, Prolia$809$858,51442 claims
PfizerOctagam$544$309,24611 claims
Johnson & JohnsonRemicade$1,868$210,18241 claims
E.r. Squibb & Sons, L.L.C.Orencia$279$161,01736 claims
GSKBenlysta$22$134,25529 claims
AbbVieRinvoq$1,391$96,39213 claims
Fresenius Kabi USA, LLCSodium Chloride$137$21291 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Indiana

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →